Sandeep Athalye is the Chief Executive Officer of Kashiv BioSciences, a biosimilar company focused on developing and commercializing complex injectable.
Dr. Sandeep Athalye is the Chief Executive Officer of Kashiv BioSciences, a biosimilar company focused on developing and commercializing complex injectable therapies. He has held this role since November 2024, leading the company through its acquisition by Amneal Pharmaceuticals in April 2026.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide